Universal Ibogaine Inc. Share Price Toronto S.E.
Equities
IBO
CA69379R1082
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -33.33% | -33.33% | +100.00% |
04-22 | Universal Ibogaine Inc. Elects Ken Cranwill as Board of Director | CI |
04-22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
Sales 2022 | 1.07 1.46 84.44 | Sales 2023 | 1.03 1.4 81.22 | Capitalization | 2.87M 3.91M 227M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.6M -789M | Net income 2023 | -2M -2.72M -158M | EV / Sales 2022 | 8,069,982 x |
Net Debt 2022 | 1.01M 1.38M 79.77M | Net Debt 2023 | 2.46M 3.35M 194M | EV / Sales 2023 | 5,181,017 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-1.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
1 day | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 09/01/22 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 09/01/22 |
James Duncan
BRD | Director/Board Member | - | 30/09/23 |
1st Jan change | Capi. | |
---|---|---|
-28.75% | 70.3B | |
+2.04% | 27.46B | |
-6.19% | 17.8B | |
+2.32% | 17.46B | |
+2.10% | 15.46B | |
+7.06% | 13.49B | |
+10.80% | 13.06B | |
+71.31% | 12.96B | |
+75.96% | 12.56B |
- Stock Market
- Equities
- IBO Stock
- IBO Stock